HCPCS code J9060: Cisplatin injection, per 10 mg2026 Medicare rate & RVUs in Texas
Reports cisplatin supplied for cancer treatment in 10 mg units, commonly administered intravenously as part of an antineoplastic regimen.
CMS doesn’t publish an office rate for J9060 in Texas.
Medicare allowed amount for participating (non-QP) physicians, before deductible, coinsurance and claim adjustments. Not a patient’s bill or a hospital charge.
Your location
On this page 9 sections
What J9060 covers
Cisplatin is an antineoplastic drug supplied as a powder or solution for injection and commonly given intravenously in cancer treatment regimens. Oncology practices and hospital outpatient departments typically report the drug when cisplatin is furnished for a patient’s treatment. The drug code represents the medication, not the infusion or injection service used to administer it.
CMS excludes this code from the physician fee schedule under status E. When Medicare covers the drug, payment is made through another payment method; for a covered Part B drug, CMS generally uses its quarterly Average Sales Price drug pricing files. Special Medicare coverage instructions apply. Each HCPCS unit represents 10 mg of cisplatin, so report units based on the amount represented by the code for the drug furnished.
This summary was written with AI assistance from CMS physician fee schedule data and checked against the CMS billing rules shown here. Rates on this page come directly from CMS files.
Where J9060 pays more and less in Texas
The same RVUs, adjusted for each area’s costs. Open a locality for its calculation, history and nearby areas.
8 of 8 payment localities
| Payment locality | Office | Facility |
|---|---|---|
| Austin, TX | Unavailable | Unavailable |
| Beaumont, TX | Unavailable | Unavailable |
| Brazoria, TX | Unavailable | Unavailable |
| Dallas, TX | Unavailable | Unavailable |
| Fort Worth, TX | Unavailable | Unavailable |
| Galveston, TX | Unavailable | Unavailable |
| Houston, TX | Unavailable | Unavailable |
| Rest of Texas | Unavailable | Unavailable |
How the J9060 rate is calculated
Each of J9060’s three RVUs is multiplied by a geographic index (GPCI) for the payment locality, added up, and multiplied by the conversion factor. Drag the indexes or enter a ZIP to see what moves the rate.
How the rate is built · J9060
RVUs × geographic indexes × conversion factor
Work0.00
0.00 RVUs× 1.000 GPCI
Practice expense0.00
0.00 RVUs× 1.000 GPCI
Malpractice0.00
0.00 RVUs× 1.000 GPCI
Adjusted RVUs
0.0000
Conversion factor
$33.4009
Medicare rate
$0.00
Every GPCI starts at 1.000, the national rate. Enter a ZIP or drag a slider.
Payment rules and modifiers for J9060
J9060 has no global surgery period, no multiple-procedure, bilateral or assistant-at-surgery adjustment, and no professional/technical split. What changes the payment is where the service happens: the place of service on the claim decides whether Medicare pays the office or the facility rate.
Place of service · J9060
Which rate does Medicare pay?
The POS code on the claim line (CMS-1500 box 24B).
POS 11 · non-facility rate · national
—
J9060 isn’t priced in this setting.
J9060 compared with similar codes
Compare codes · National
4 codes, side by side
How to choose
- J9045CarboplatinPer 50 mg
- J9045 identifies carboplatin, while J9060 identifies cisplatin. Use the drug code matching the medication furnished.
- 96413Chemo IV infusionInitial drug, first hour
- 96413 describes a qualifying chemotherapy infusion administration service; J9060 reports the cisplatin drug in 10 mg units.
- 96417Chemotherapy infusionAdditional sequential drug
- 96417 describes qualifying sequential chemotherapy infusion administration, not a drug or drug-dose unit. J9060 identifies cisplatin.
J9060 billing questions
How many units represent 100 mg of cisplatin?
The code represents 10 mg per unit, so 100 mg corresponds to 10 units.
Is this code for the cisplatin drug or its administration?
It reports the cisplatin drug. Report a chemotherapy administration service separately when the service is performed and the applicable coding requirements are met.
How does this differ from J9045?
J9060 identifies cisplatin; J9045 identifies carboplatin. Select the code for the drug actually furnished, not simply because both are platinum chemotherapy agents.
How does Medicare treat this code?
CMS assigns physician fee schedule status E, excluding it from the physician fee schedule. When covered, Medicare pays under another method; covered Part B drug payment generally uses CMS quarterly ASP drug pricing files.
Where these rates come from
FeeBase calculates base physician payments from CMS work, practice-expense and malpractice RVUs, adjusted by each locality’s geographic indexes and the conversion factor. Services without a published rate are labeled, never given a made-up amount. Amounts are Medicare allowed amounts before claim adjustments: not a patient’s bill or a commercial rate.
CMS RVU26D · effective Oct 1, 2026 through the day before Jan 1, 2027
Fee sheets · Coming soon
Put J9060 and the rest of your codes on one sheet
Your codes at your locality, with payer contracts beside Medicare.
Join the waitlist